Literature DB >> 8787127

D1 and D2 receptor regulation of preproenkephalin and preprodynorphin mRNA in rat striatum following acute injection of amphetamine or methamphetamine.

J Q Wang1, J F McGinty.   

Abstract

Our previous work has demonstrated a dose-dependent induction of striatal preprodynorphin (PPD) in response to a single injection of the psychostimulants amphetamine (AMPH) or methamphetamine (METH). In the present study, dose-response effects of acute administration of these stimulants on preproenkephalin (PPE) mRNA expression in the rat striatum were investigated with quantitative in situ hybridization histochemistry 3 h after injection. Acute AMPH or METH at equimolar doses (3.75, 7.5, 15, and 30 mumol/kg) significantly increased PPE mRNA expression in dorsal (caudoputamen), but not ventral (nucleus accumbens), striatum in a dose-dependent fashion. In addition, the role of D1 and D2 dopamine receptors in mediating AMPH- and METH-stimulated PPE and PPD expression was also evaluated by using subtype-specific antagonists. Pretreatment of rats with SCH 23390 (0.1 mg/kg, i.p.), a selective D1 receptor antagonist, completely blocked acute AMPH (21 mumol/kg, i.p.)- or METH (21 mumol/kg, i.p.)-induced PPE as well as PPD mRNA expression in the caudoputamen. Pretreatment with eticlopride (0.5 mg/kg, i.p.), a selective D2 receptor antagonist, also blocked PPD induction by the two stimulants, but PPE induction was unaffected. Furthermore, SCH 23390 decreased, and eticlopride elevated, constitutive PPE mRNA levels in the caudoputamen. Neither antagonist had a significant effect on the basal level of PPE or PPD mRNA in the nucleus accumbens. These results demonstrate a clear dose-related responsiveness of PPE gene expression in striatal neurons in response to acute administration of amphetamines, although the intensity of the response is far less than that for striatal PPD. Furthermore, both D1 and D2 subtypes of dopamine receptors mediate AMPH- and METH-stimulated striatal PPD mRNA expression, whereas D1 receptor activation alone mediates amphetamine-stimulated PPE mRNA expression in the rat striatum.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8787127     DOI: 10.1002/(SICI)1098-2396(199602)22:2<114::AID-SYN4>3.0.CO;2-G

Source DB:  PubMed          Journal:  Synapse        ISSN: 0887-4476            Impact factor:   2.562


  19 in total

1.  Mephedrone alters basal ganglia and limbic dynorphin systems.

Authors:  Christopher L German; Mario E Alburges; Amanda J Hoonakker; Annette E Fleckenstein; Glen R Hanson
Journal:  Synapse       Date:  2014-09-08       Impact factor: 2.562

2.  Amphetamine up-regulates activator of G-protein signaling 1 mRNA and protein levels in rat frontal cortex: the role of dopamine and glucocorticoid receptors.

Authors:  M Schwendt; J F McGinty
Journal:  Neuroscience       Date:  2010-03-15       Impact factor: 3.590

3.  Acute nicotine changes dynorphin and prodynorphin mRNA in the striatum.

Authors:  Raffaella Isola; Hailin Zhang; Gopi A Tejwani; Norton H Neff; Maria Hadjiconstantinou
Journal:  Psychopharmacology (Berl)       Date:  2008-09-21       Impact factor: 4.530

4.  Microdialysis and mass spectrometric monitoring of dopamine and enkephalins in the globus pallidus reveal reciprocal interactions that regulate movement.

Authors:  Omar S Mabrouk; Qiang Li; Peng Song; Robert T Kennedy
Journal:  J Neurochem       Date:  2011-05-25       Impact factor: 5.372

5.  Fluoxetine potentiation of methylphenidate-induced neuropeptide expression in the striatum occurs selectively in direct pathway (striatonigral) neurons.

Authors:  Vincent Van Waes; Betsy Carr; Joel A Beverley; Heinz Steiner
Journal:  J Neurochem       Date:  2012-07-23       Impact factor: 5.372

6.  Neonatal +-methamphetamine exposure in rats alters adult locomotor responses to dopamine D1 and D2 agonists and to a glutamate NMDA receptor antagonist, but not to serotonin agonists.

Authors:  Devon L Graham; Robyn M Amos-Kroohs; Amanda A Braun; Curtis E Grace; Tori L Schaefer; Matthew R Skelton; Michael T Williams; Charles V Vorhees
Journal:  Int J Neuropsychopharmacol       Date:  2012-03-06       Impact factor: 5.176

7.  Neuropharmacological profile of aqueous extract of Anaphe venata larva (Notondotidae) in rats.

Authors:  K D S Bamitale; M A Akanmu; Otas E Ukponmwan
Journal:  Afr J Tradit Complement Altern Med       Date:  2011-04-02

8.  Amphetamine-induced locomotion and gene expression are altered in BDNF heterozygous mice.

Authors:  A J Saylor; J F McGinty
Journal:  Genes Brain Behav       Date:  2008-08-04       Impact factor: 3.449

9.  Habit formation and the loss of control of an internal clock: inverse relationship between the level of baseline training and the clock-speed enhancing effects of methamphetamine.

Authors:  Ruey-Kuang Cheng; Oshri L Hakak; Warren H Meck
Journal:  Psychopharmacology (Berl)       Date:  2007-04-27       Impact factor: 4.530

10.  Fluoxetine potentiation of methylphenidate-induced gene regulation in striatal output pathways: potential role for 5-HT1B receptor.

Authors:  Vincent Van Waes; Sarah Ehrlich; Joel A Beverley; Heinz Steiner
Journal:  Neuropharmacology       Date:  2014-09-16       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.